MONOCYTE TISSUE FACTOR IN TREATED HODGKINS-DISEASE

被引：6

作者：

HAIRE, WD

PIRRUCCELLO, SJ

CARSON, SD

机构：

[1] Department of Internal Medicine and, University of Nebraska Medical Center, Omaha, NE

[2] Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

来源：

LEUKEMIA & LYMPHOMA | 1994年 / 12卷 / 3-4期

关键词：

MONOCYTE TISSUE FACTOR; HODGKINS DISEASE;

D O I：

10.3109/10428199409059597

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thrombosis is a recognized complication of Hodgkin's disease. The mechanism for thrombosis in this setting is not known. We determined the functional expression of tissue factor on peripheral blood monocytes in 14 consecutive patients with relapsed Hodgkin's disease. Marked elevations in activity were present in slightly more than half of the subjects. Tissue factor activities varied over 75-fold. Patients with higher tissue factor levels tended to be males who had not undergone splenectomy as part of their staging evaluation. Definite thrombotic complications occurred in three of the patients with the highest levels of tissue factor. While monocyte tissue factor may play a contributory role in the development of thrombotic complications in some patients with relapsed Hodgkin's disease, marked elevation of tissue factor is characteristic of only a subpopulation of these patients. This suggests that patient-, therapy- or disease-specific variables, including tissue factor, may determine the development of thrombosis in these patients.

引用

页码：259 / 263

页数：5

共 24 条

[1]

Seifter E.J., Young R.C., Longo D.L., Deep venous thrombosis during therapy for Hodgkin's disease, Cancer Treat. Rep., 69, pp. 1011-1013, (1985)

[2]

Schreiber D.P., Kapp D.S., Axillary-subclavian vein thrombosis following combination chemotherapy and radiation therapy in lymphoma, Int. J. Radiat. Oncol. Biol. Phys., 12, pp. 391-395, (1986)

[3]

Conlan M.G., Haire W.D., Lieberman R.P., Lund G.B., Kessinger A., Armitage J.O., Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation, Bone Marrow Transplantation, 7, pp. 235-240, (1991)

[4]

Conlan M.G., Haire W.D., Armitage J.O., Kessinger A., Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma, Bone Marrow Transplantation, 7, pp. 475-479, (1991)

[5]

Nemerson Y., Tissue factor and hemostasis, Blood, 71, pp. 1-8, (1988)

[6]

Nemerson Y., Repke D., Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor, Thrombosis Res., 40, pp. 351-358, (1985)

[7]

Osteoid B., Rappaport S.I., Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiation of blood coagulation, Proc. Nat. Acad. Sci., 74, pp. 5254-5260, (1977)

[8]

Nemerson Y., The reaction between bovine brain tissue factor and factors VII and X, Biochemistry, 5, pp. 601-608, (1966)

[9]

Bevilacqua M.P., Pober J.S., Majeau G.R., Cotran R.S., Gimbrone M.A., Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells, J. Exp. Med., 160, pp. 618-623, (1984)

[10]

Dinarello C.A., Interleukin-1 and the pathogenesis of the acute-phase response, N. Engl. J. Med., 311, pp. 1413-1418, (1984)

← 1 2 3 →